Perindopril/Ambrosin Combination Mitigates Dextran Sulfate Sodium-Induced Colitis in Mice: Crosstalk between Toll-Like Receptor 4, the Pro-Inflammatory Pathways, and SIRT1/PPAR-γ Signaling

MLA

Ahmed M. Kabel, et al. “Perindopril/Ambrosin Combination Mitigates Dextran Sulfate Sodium-Induced Colitis in Mice: Crosstalk between Toll-Like Receptor 4, the Pro-Inflammatory Pathways, and SIRT1/PPAR-γ Signaling.” Pharmaceuticals, vol. 15, no. 5, May 2022, p. 600. EBSCOhost, https://doi.org/10.3390/ph15050600.

APA

Ahmed M. Kabel, Aliaa Atef, Hany M. Borg, Azza A. K. El-Sheikh, Hana J. Al Khabbaz, Hany H. Arab, & Remon S. Estfanous. (2022). Perindopril/Ambrosin Combination Mitigates Dextran Sulfate Sodium-Induced Colitis in Mice: Crosstalk between Toll-Like Receptor 4, the Pro-Inflammatory Pathways, and SIRT1/PPAR-γ Signaling. Pharmaceuticals, 15(5), 600. https://doi.org/10.3390/ph15050600

Chicago

Ahmed M. Kabel, Aliaa Atef, Hany M. Borg, Azza A. K. El-Sheikh, Hana J. Al Khabbaz, Hany H. Arab, and Remon S. Estfanous. 2022. “Perindopril/Ambrosin Combination Mitigates Dextran Sulfate Sodium-Induced Colitis in Mice: Crosstalk between Toll-Like Receptor 4, the Pro-Inflammatory Pathways, and SIRT1/PPAR-γ Signaling.” Pharmaceuticals 15 (5): 600. doi:10.3390/ph15050600.